Provided by Tiger Fintech (Singapore) Pte. Ltd.

Harmony Biosciences Holdings, Inc.

29.44
+0.08000.27%
Post-market: 29.440.00000.00%16:26 EDT
Volume:415.04K
Turnover:12.23M
Market Cap:1.69B
PE:11.73
High:29.71
Open:29.44
Low:28.92
Close:29.36
Loading ...

HRMY Down 10.8% in Six Months: How Should You Play the Stock?

Zacks
·
20 Mar

Mizuho Adjusts PT on Harmony Biosciences Holdings to $44 From $42, Maintains Outperform Rating

MT Newswires Live
·
17 Mar

Harmony Biosciences to Participate in Upcoming Investor Conferences

Business Wire
·
04 Mar

Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Simply Wall St.
·
28 Feb

UBS Adjusts Price Target on Harmony Biosciences to $55 From $56, Keeps Buy Rating

MT Newswires Live
·
27 Feb

Harmony Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
27 Feb

Harmony Biosciences price target lowered to $70 from $75 at H.C. Wainwright

TIPRANKS
·
27 Feb

Stock Track | Harmony Biosciences Plummets 5% on Pipeline and Generic Competition Concerns

Stock Track
·
26 Feb

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?

Zacks
·
26 Feb

Cautious Outlook: Sell Rating for Harmony Biosciences Due to Pipeline Concerns and Generic Competition Risks

TIPRANKS
·
26 Feb

Harmony Biosciences Holdings Inc (HRMY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ...

GuruFocus.com
·
26 Feb

Harmony Biosciences Files for Mixed Shelf - SEC Filing

THOMSON REUTERS
·
26 Feb

Harmony Biosciences: Sales Agreement Prospectus Supplement Covering Offering of up to $200 Mln Common Stock That May Be Issued From Time to Time

THOMSON REUTERS
·
26 Feb

Stock Track | Harmony Biosciences (HRMY) Soars 5.02% on Strong Q4 Results, Pitolisant Patent Win, Pipeline Progress

Stock Track
·
26 Feb

Harmony Biosciences (HRMY) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
26 Feb

Harmony Biosciences Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
25 Feb

BUZZ-U.S. STOCKS ON THE MOVE-  Eli Lilly, Krispy Kreme, PayPal

Reuters
·
25 Feb

Harmony Biosciences Holdings, Inc. (HRMY) Tops Q4 Earnings and Revenue Estimates

Zacks
·
25 Feb

Harmony Biosciences Price Target Maintained With a $50.00/Share by Needham

Dow Jones
·
25 Feb

BUZZ-Harmony Biosciences rises on quarterly profit and sales beat

Reuters
·
25 Feb